JAMES H. WALLACE, JR.
phone: 202-789-3960
fax: 202-789-1813
EDUCATION
- J.D., Georgetown University Law Center
- Associate Editor, Georgetown Law Journal
- B.S.E.E., University of South Carolina; Tau Beta Pi; Eta Kappa Nu; Pi Mu Epsilon
SUBSTANTIVE PRACTICE AREAS
- Intellectual Property
- Antitrust
BAR ADMISSIONS
- District of Columbia
- Supreme Court of the United States
COURT ADMISSIONS
- U.S. Courts of Appeals for the Federal, and District of Columbia Circuits
- U.S. Patent and Trademark Office
PROFESSIONAL AFFILIATIONS
- US Patent & Trademark Office, Patent Examiner
- US Department of Justice, Antitrust Division, Trial Attorney
- Kirkland & Ellis, Partner
- Wiley Ren, Partner
Jim Wallace has more than 30 years of experience litigating patents in the fields of communications satellites, data transmission, network interface devices, Internet business methods, pharmaceuticals, biotechnology, and semiconductors.
Representative Experience
• Secured, on behalf of client NTP Inc., a $612.5 million patent infringement settlement with Research In Motion Ltd. (RIM), the maker of BlackBerry wireless email devices. The settlement, one of the largest ever of its kind, resolved a fiercely contested, high-profile patent case stemming from a 2002 jury trial in which the firm successfully argued that RIM's core BlackBerry line of
wireless email products, software and services willfully infringed NTP patents.
• Litigated numerous pharmaceutical patent cases, including aripiprazole (Abilify®), cetuximab (Erbitux®), loratadine (Claritin®), oxybutynin chloride (Ditropan XL®), carbidopa/levodopa (Sinemet® CR), tamoxifen citrate (Nolvadex®), allopurinol (Zyloprim®), tPA (Activase®), omeprazole (Prilosec®), cyclobenzaprine HCI (Amrix®), erlotinib (Tarceva®), interferon (Roferon®-A), levofloxacin (Levaquin®), dutasteride (Avodart®), fenofibrate (Antara®), and tolterodine tartrate (Detrol® LA).
• Represented a developer of electronic imaging systems in a patent infringement action against 17 Japanese and Korean manufacturers involving the seeing-eye elements of camcorders and fax machines that convert light into electrons, known as charge coupled device (CCD) technology.
• Successfully represented clients in 337 patent infringement actions before the U.S. International Trade Commission (USITC), including a case involving novel microwave filters on satellites that, based upon their light weight, enabled increased satellite life.
• Successfully defended Royal Crown Cola in major antitrust challenge to exclusive geographic franchise agreements.
• On behalf of Royal Crown Cola successfully challenged, under the antitrust law, the proposed Pepsi/Seven Up and Coke/Dr. Pepper mergers.
• Secured a victory for client ARM Ltd. in defense of claims of patent infringement pertaining to the design of microprocessors.
• Filed an amicus brief, on behalf of Nobel Prize winner James D. Watson, in the landmark Myriad Genetics Inc. human gene patent case before the Supreme Court of the United States.
LET'S WORK TOGETHER
CGL is currently engaged in dozens of cases from product defect class actions to antitrust litigation to civil rights advocacy.
If you feel we could represent you in any of our current cases or in a new case, we would love to hear from you.